Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
Open Access
- 20 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 45, 100596
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Cytotoxic Effect of Zoledronic Acid-Loaded Bone Cement on Giant Cell Tumor, Multiple Myeloma, and Renal Cell Carcinoma Cell LinesJournal of Bone and Joint Surgery, 2010
- Expression of bone morphogenetic proteins in giant cell tumor of bone.2009
- Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorptionSeminars in Cell & Developmental Biology, 2008
- Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cellsBone, 2008
- Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case–control studyBone, 2008
- Bone safety of long-term bisphosphonate treatmentCurrent Medical Research and Opinion, 2004
- Bisphosphonates Induce Apoptosis of Stromal Tumor Cells in Giant Cell Tumor of BoneCalcified Tissue International, 2004
- Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration.2003
- Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.2003
- Platelet-Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory FactorJournal of Bone and Mineral Research, 2002